Long-term Survival of Transplanted Islets by Targeting B Cells Rather than T...
JDRF-funded researchers have shown that a treatment that specifically targets and depletes B cells can promote the survival of transplanted islets in diabetic nonhuman primates. Many factors are...
View ArticleGlucose-Responsive, Insulin-Secreting Cells Produced from Embryonic Stem Cells
Scientists from the San Diego, California–based company Novocell successfully developed a primitive cell line from human embryonic stem cells that, when implanted into mice, was able to reverse...
View ArticleCombination Therapy May Help in Islet Transplant Failure
JDRF-funded scientists provided new evidence that a two-drug combination can extend the function of pancreatic islet transplants that have begun to fail and restore insulin independence in some...
View ArticleJDRF Convenes First-Ever Encapsulation Consortium
For people living with type 1 diabetes (T1D), establishing insulin independence by implanting insulin-producing beta cells into the body would be life changing. But a challenge to this potential...
View ArticleMouse T1D Prevention Study Highlights Approach to Accelerate Translational...
JDRF has a plan for creating a world without type 1 diabetes (T1D) that focuses on driving promising therapies through the R&D pipeline and into the hands of individuals with T1D. A critical step...
View Article
